Preimplantation Genetic Testing for Aneuploidy (PGT-A)
Preimplantation Genetic Testing for Monogenic Disorders (PGT-M)
Clinical Whole Exome Sequencing (cWES)
Search
Preimplantation Genetic Testing for Aneuploidy (PGT-A)
PGT-A, or preimplantation genetic testing for aneuploidies, is a genetic test of the embryo produced during IVF treatment.
PGT-A identifies chromosomally normal embryos to improve your chance for a successful and healthy pregnancy and baby.
BGI’s VISTA™ PGT-A uses single-cell whole genome amplification and low-coverage genome-wide sequencing technology to detect aneuploidy for all 46 chromosomes, deletions or duplications larger than 4Mb.
Embryonic aneuploidy, most often arising from meiotic errors in oocytes, is the major cause of early pregnancy wastage. By using this test:
Miscarriage rates can be reduced
Fewer cycles of IVF treatment will be needed (less time and money)
Pregnancy rates per transfer can be higher
Detect aneuploidy for all 46 chromosomes, deletions or duplications >4Mb
99.9% accuracy with NGS
High quality, low price
VISTA™ PGT-A is recommended for:
Advanced maternal age(≥35 years old)
Recurrent miscarriages
IVF failures: two or more IVF failures
Male factor: considering a low quantity and/or quality of sperm
A personal or family history of chromosomal abnormalities
Turnaround times for specific tests vary as per the table below. TATs are calculated from the time the sample is received and accepted at the laboratory.
| Product Name | Product Code | TAT |
|---|---|---|
| Vista™ Preimplantation Genetic Testing for Aneuploidy (PGT-A) (Frozen) | SDX3001 | 15 days |
| Vista™ Rapid Preimplantation Genetic Testing for Aneuploidy (PGT-A) (Fresh) | SDX3002 | 72 hours |
| Vista™ Preimplantation Genetic Testing for Gender Detection (Frozen) | SDX3011 | 15 days |
| Vista™ Preimplantation Genetic Testing for Gender Detection (Fresh) | SDX3012 | 72 hours |
Genalive Genetic Counselors are available to Healthcare providers to help navigate which test is best for their patient.
